Idorsia Stock Net Income
| IDIA Stock | CHF 3.97 0.11 2.85% |
As of the 16th of February 2026, Idorsia retains the Market Risk Adjusted Performance of (1.12), downside deviation of 3.81, and Risk Adjusted Performance of 0.0782. Idorsia technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Idorsia jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if Idorsia is priced fairly, providing market reflects its last-minute price of 3.97 per share.
Idorsia Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 9.3635 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -237.4 M | -249.3 M | |
| Net Loss | -237.4 M | -249.3 M | |
| Net Loss | -237.4 M | -249.3 M | |
| Net Loss | (1.67) | (1.75) | |
| Net Income Per E B T | 0.90 | 0.80 |
Idorsia | Net Income |
The evolution of Net Income for Idorsia provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Idorsia compares to historical norms and industry peers.
Latest Idorsia's Net Income Growth Pattern
Below is the plot of the Net Income of Idorsia over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Idorsia financial statement analysis. It represents the amount of money remaining after all of Idorsia operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Idorsia's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Idorsia's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (263.76 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Idorsia Net Income Regression Statistics
| Arithmetic Mean | (364,542,863) | |
| Coefficient Of Variation | (47.73) | |
| Mean Deviation | 113,639,375 | |
| Median | (335,143,000) | |
| Standard Deviation | 173,983,231 | |
| Sample Variance | 30270.2T | |
| Range | 813.6M | |
| R-Value | (0.11) | |
| Mean Square Error | 31878.3T | |
| R-Squared | 0.01 | |
| Significance | 0.67 | |
| Slope | (3,881,865) | |
| Total Sum of Squares | 484322.6T |
Idorsia Net Income History
Idorsia Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Idorsia is extremely important. It helps to project a fair market value of Idorsia Stock properly, considering its historical fundamentals such as Net Income. Since Idorsia's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Idorsia's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Idorsia's interrelated accounts and indicators.
Click cells to compare fundamentals
Idorsia 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Idorsia's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Idorsia.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Idorsia on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Idorsia or generate 0.0% return on investment in Idorsia over 90 days. Idorsia is related to or competes with Basilea Pharmaceutica, PolyPeptide Group, Kuros Biosciences, Molecular Partners, Santhera Pharmaceuticals, Medartis Holding, and Newron Pharmaceuticals. Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs More
Idorsia Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Idorsia's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Idorsia upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.81 | |||
| Information Ratio | 0.0703 | |||
| Maximum Drawdown | 22.3 | |||
| Value At Risk | (6.39) | |||
| Potential Upside | 8.57 |
Idorsia Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Idorsia's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Idorsia's standard deviation. In reality, there are many statistical measures that can use Idorsia historical prices to predict the future Idorsia's volatility.| Risk Adjusted Performance | 0.0782 | |||
| Jensen Alpha | 0.3745 | |||
| Total Risk Alpha | 0.0431 | |||
| Sortino Ratio | 0.0776 | |||
| Treynor Ratio | (1.13) |
Idorsia February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0782 | |||
| Market Risk Adjusted Performance | (1.12) | |||
| Mean Deviation | 2.93 | |||
| Semi Deviation | 3.46 | |||
| Downside Deviation | 3.81 | |||
| Coefficient Of Variation | 1150.65 | |||
| Standard Deviation | 4.21 | |||
| Variance | 17.7 | |||
| Information Ratio | 0.0703 | |||
| Jensen Alpha | 0.3745 | |||
| Total Risk Alpha | 0.0431 | |||
| Sortino Ratio | 0.0776 | |||
| Treynor Ratio | (1.13) | |||
| Maximum Drawdown | 22.3 | |||
| Value At Risk | (6.39) | |||
| Potential Upside | 8.57 | |||
| Downside Variance | 14.51 | |||
| Semi Variance | 11.94 | |||
| Expected Short fall | (3.29) | |||
| Skewness | 0.8421 | |||
| Kurtosis | 2.22 |
Idorsia Backtested Returns
Idorsia appears to be risky, given 3 months investment horizon. Idorsia holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Idorsia, which you can use to evaluate the volatility of the firm. Please utilize Idorsia's Market Risk Adjusted Performance of (1.12), downside deviation of 3.81, and Risk Adjusted Performance of 0.0782 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Idorsia holds a performance score of 8. The company retains a Market Volatility (i.e., Beta) of -0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Idorsia are expected to decrease at a much lower rate. During the bear market, Idorsia is likely to outperform the market. Please check Idorsia's sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether Idorsia's current trending patterns will revert.
Auto-correlation | 0.04 |
Virtually no predictability
Idorsia has virtually no predictability. Overlapping area represents the amount of predictability between Idorsia time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Idorsia price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Idorsia price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Idorsia Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Idorsia reported net income of (263.76 Million). This is 177.28% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all Switzerland stocks is 146.19% higher than that of the company.
Idorsia Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Idorsia's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Idorsia could also be used in its relative valuation, which is a method of valuing Idorsia by comparing valuation metrics of similar companies.Idorsia is currently under evaluation in net income category among its peers.
Idorsia Fundamentals
| Return On Equity | -64.61 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.51) % | ||||
| Operating Margin | (0.97) % | ||||
| Current Valuation | 2.18 B | ||||
| Shares Outstanding | 245.72 M | ||||
| Shares Owned By Insiders | 30.52 % | ||||
| Shares Owned By Institutions | 14.22 % | ||||
| Price To Book | 27.65 X | ||||
| Price To Sales | 4.23 X | ||||
| Revenue | 112.51 M | ||||
| Gross Profit | 93.72 M | ||||
| EBITDA | (319.49 M) | ||||
| Net Income | (263.76 M) | ||||
| Cash And Equivalents | 811.85 M | ||||
| Cash Per Share | 6.19 X | ||||
| Total Debt | 1.26 B | ||||
| Debt To Equity | 112.20 % | ||||
| Current Ratio | 7.57 X | ||||
| Book Value Per Share | (4.88) X | ||||
| Cash Flow From Operations | (370.23 M) | ||||
| Earnings Per Share | (0.62) X | ||||
| Target Price | 2.0 | ||||
| Beta | 1.7 | ||||
| Market Capitalization | 759.27 M | ||||
| Total Asset | 505.89 M | ||||
| Retained Earnings | (3.41 B) | ||||
| Working Capital | (187.72 M) | ||||
| Net Asset | 505.89 M |
About Idorsia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Idorsia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Idorsia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Idorsia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Idorsia Stock Analysis
When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.